Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements benefit large pharmacy chains and intermediaries as much—or more—than the patients Congress ultimately intended to help with 340B has created over 30 years ago?
Related Posts
What’s So Bad About Nicotine?
This article was featured in the One Story to Read Today newsletter. Sign up for it here. For the better part of the past century, […]
Alleges Anti-Competitive Practices & Trade Secret Theft
What You Should Know: – CureIS Healthcare, Inc., a company specializing in information technology solutions for the healthcare industry, has filed a lawsuit against EHR […]
Senate Rejects Extending ACA Tax Credits
After months of effort by lawmakers and advocacy groups to prevent the expiration of the Affordable Care Act (ACA) tax credits for at least 20 […]